Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06755606

Evaluation of the Effect of an Emergency Department Information Video on the Risk of Post-Traumatic Stress Disorder 30 Days After an Emergency Visit.

Post-traumatic stress disorder (PTSD) is a psychological disorder characterized by the re-experiencing of distressing symptoms, avoidance of traumatic memories and physiological hyperarousal in people who have been exposed to a traumatic event. The consequences of PTSD are manifold: financial, quality of life, absenteeism, morbidity, and mortality.

An emergency department visit can be a traumatic event and associated with anxiety.

Studies have explored the prevalence and factors associated with the occurrence of PTSD among a selected population of patients admitted to the emergency department for either cardiological or traumatological reasons. The prevalence of PTSD at 1 month varied among these populations, from 12% to 25%.

Several factors have been described that could be independently associated with an increased risk of developing PTSD: factors linked to the patient himself (basal state and severity of acute pathology) or to the patient pathway (care structure, care modalities, waiting time). Given the serious medical, psycho-social and economic consequences of PTSD, it is important to identify the risk factors that can be controlled during a patient's stay in the emergency department.

In 2025, a general information procedure for patients and next of kin will be deployed in three emergency departments.

The aim of this procedure is to improve the quality of the information provided to emergency patients, thereby enhancing the experience of patients and those accompanying them. It will consist of video support delivering standardized information to patients from the moment they arrive in the emergency department until they are discharged. These videos will describe the patient's journey through the emergency department.

The aim of this study is to evaluate the effect of this information procedure on the risk of developing PTSD.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years
  • Triage level 1, 2, 3 by the triage nurse (according to CIMU, FRENCH or other scale used locally)
  • Non-opposition to participation in the study after information and delivery of the information note
  • Possibility of 30-day follow-up (self-questionnaire to be completed by e-mail)
  • Patient with cognitive or sensory capacity to view and understand information videos

Exclusion criteria

  • Inability to consent (neurological disorder, coma, acute intoxication, cognitive impairment)
  • Patient does not have a good understanding of the French language.
  • Estimated life expectancy less than 6 months
  • Participation in other clinical intervention research

Treatment and study plan

Primary outcomes

  1. Occurence PTSD

    Time frame: DaAy 30

    assessed by calculation of PCL-5 score

Secondary outcomes

  1. Identify factors associated with the occurrence of PTSD

    Time frame: Day 30

    Identify factors associated with the occurrence of PTSD in relation to the acute pathology, the patient's baseline condition, and the patient's pathway through the emergency department.

  2. HAD score at D30

    Time frame: Day 30

Study contacts

Contact information is provided by the study sponsor or research team.

Jennifer TRUCHOT, MD, PhD

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Registry information

Acronym: VISU

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jan 1, 2025
Registry last updated
Jan 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.